πŸ‡ΊπŸ‡Έ FDA
Patent

US 9533987

Heterocyclic derivates

granted A61PA61P1/00A61P1/04

Quick answer

US patent 9533987 (Heterocyclic derivates) held by KalVista Pharmaceuticals Limited expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KalVista Pharmaceuticals Limited
Grant date
Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00